Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

379 ARTÍCULOS , VIENDO DEL 196 AL 210

Platelets as potential link between diabetes and Alzheimer's disease

Randriamboavonjy V, Sopova K, Stellos K, Laske C.

Curr Alzheimer Res. 2014;11(9):862-8. doi: 10.2174/156720501109141013115258.

Amyloid beta peptide immunotherapy in Alzheimer disease

Delrieu J, Ousset PJ, Voisin T, Vellas B.

Rev Neurol (Paris). 2014 Dec;170(12):739-48. doi: 10.1016/j.neurol.2014.10.003. Epub 2014 Nov 6.

Should development of Alzheimer's disease-specific intravenous immunoglobulin be considered?

Loeffler DA.

J Neuroinflammation. 2014 Dec 5;11:198. doi: 10.1186/s12974-014-0198-z.

Phytomedicines as potential inhibitors of β amyloid aggregation: significance to Alzheimer's disease

Kumar NS, Nisha N.

Chin J Nat Med. 2014 Nov;12(11):801-18. doi: 10.1016/S1875-5364(14)60122-9.

Severe hyponatremia due to escitalopram treatment in an elderly adult with Alzheimer's disease

Soysal P, Isik AT.

J Am Geriatr Soc. 2014 Dec;62(12):2462-3. doi: 10.1111/jgs.13149.

Donepezil can improve daily activities and promote rehabilitation for severe Alzheimer's patients in long-term care health facilities

Meguro K, Ouchi Y, Akanuma K, Meguro M, Kasai M.

BMC Neurol. 2014 Dec 17;14:243. doi: 10.1186/s12883-014-0243-7.

Resveratrol as a therapeutic agent for Alzheimer's disease

Ma T, Tan MS, Yu JT, Tan L.

Biomed Res Int. 2014;2014:350516. doi: 10.1155/2014/350516. Epub 2014 Nov 26.

Long-term efficacy and toxicity of cholinesterase inhibitors in the treatment of Alzheimer disease

Hogan DB.

Can J Psychiatry. 2014 Dec;59(12):618-23. doi: 10.1177/070674371405901202.

A possible link of gut microbiota alteration in type 2 diabetes and Alzheimer's disease pathogenicity: an update

Alam MZ, Alam Q, Kamal MA, Abuzenadah AM, Haque A.

CNS Neurol Disord Drug Targets. 2014 Apr;13(3):383-90. doi: 10.2174/18715273113126660151.

Autophagy dysfunction and its link to Alzheimer's disease and type II diabetes mellitus

Wilson CM, Magnaudeix A, Yardin C, Terro F.

CNS Neurol Disord Drug Targets. 2014 Mar;13(2):226-46. doi: 10.2174/18715273113126660146.

Genomic linkage between Alzheimer's disease and type 2 diabetes

Nedjadi T, Haque A, Alam Q, Gan SH, Chaudhary AG, Abuzenadah AM, Damanhouri GA, Kamal MA.

CNS Neurol Disord Drug Targets. 2014 Mar;13(2):203-12. doi: 10.2174/18715273113126660140.

A molecular bridge: connecting type 2 diabetes and Alzheimer's disease

Ahmed F, Ansari JA, Ansari ZE, Alam Q, Gan SH, Kamal MA, Ahmad E.

CNS Neurol Disord Drug Targets. 2014 Mar;13(2):312-21. doi: 10.2174/18715273113126660133.

Clinical profile of Alzheimer's disease: is the age of the patient a decisive factor? Results of the INFLUENCE study

Molinuevo JL, Casado-Naranjo I.

J Alzheimers Dis. 2014;39(2):227-32. doi: 10.3233/JAD-131433.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias